Context Therapeutics Ownership 2024 | Who Owns Context Therapeutics Now?

Overview Forecast RevenueFinancials Chart

Institutional Ownership

4.51%

Insider Ownership

2.78%

Retail Ownership

92.71%

Institutional Holders

3.00

Context Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
GREAT POINT PARTNERS LLC	46.47%	2.85%	7,419,355	7,419,355	100.00%	14,875,807	Jun 30, 2024
AVIDITY PARTNERS MANAGEMENT LP	46.47%	0.63%	7,419,355	7,419,355	100.00%	14,875,807	Jun 30, 2024
DEEP TRACK CAPITAL, LP	46.47%	0.44%	7,419,355	7,419,355	100.00%	14,875,807	Jun 30, 2024
NEXTECH INVEST LTD.	46.47%	2.50%	7,419,355	7,419,355	100.00%	14,875,807	Jun 30, 2024
BLUE OWL CAPITAL HOLDINGS LP	32.33%	2.88%	5,161,290	5,161,290	100.00%	10,348,386	Jun 30, 2024
VANGUARD GROUP INC	28.20%	0.00%	4,502,198	3,903,895	652.49%	9,026,907	Jun 30, 2024
DRIEHAUS CAPITAL MANAGEMENT LLC	14.14%	0.04%	2,258,065	2,258,065	100.00%	4,527,420	Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC	12.12%	0.23%	1,935,484	1,935,484	100.00%	3,880,645	Jun 30, 2024
ALYESKA INVESTMENT GROUP, L.P.	12.12%	0.02%	1,935,484	1,935,484	100.00%	3,851,613	Jun 30, 2024
ALLY BRIDGE GROUP (NY) LLC	11.81%	2.25%	1,886,232	1,160,281	159.83%	3,781,895	Jun 30, 2024
BLACKSTONE INC.	11.52%	0.02%	1,838,709	1,838,709	100.00%	3,686,612	Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC	10.14%	0.37%	1,619,140	1,290,323	392.41%	3,246,376	Jun 30, 2024
SIO CAPITAL MANAGEMENT, LLC	8.32%	0.72%	1,328,352	1,328,352	100.00%	2,663,346	Jun 30, 2024
VELAN CAPITAL INVESTMENT MANAGEMENT LP	8.08%	1.48%	1,290,323	1,290,323	100.00%	2,587,098	Jun 30, 2024
BLACKROCK INC.	5.33%	-	851,696	851,696	100.00%	1,707,650	Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC	4.04%	0.24%	645,161	439,227	213.29%	1,293,548	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	3.87%	0.00%	618,174	517,102	511.62%	1,239,542	Jun 30, 2024
ALTIUM CAPITAL MANAGEMENT LP	2.25%	0.29%	360,001	360,001	100.00%	721,802	Jun 30, 2024
UBS OCONNOR LLC	1.84%	0.04%	293,758	-2,917	-0.98%	588,985	Jun 30, 2024
NORTHERN TRUST CORP	1.09%	0.00%	174,497	137,278	368.84%	349,866,000	Jun 30, 2024

Context Therapeutics's largest institutional shareholder is GREAT POINT PARTNERS LLC, holding 46.47% of the company's total share outstanding, currently valued at $14.88M. The top 10 institutional shareholders own together 296.61% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BLUE OWL CAPITAL HOLDINGS LP	32.33%	2.88%	5,161,290	5,161,290	100.00%	10,348,386	Jun 30, 2024
GREAT POINT PARTNERS LLC	46.47%	2.85%	7,419,355	7,419,355	100.00%	14,875,807	Jun 30, 2024
NEXTECH INVEST LTD.	46.47%	2.50%	7,419,355	7,419,355	100.00%	14,875,807	Jun 30, 2024
ALLY BRIDGE GROUP (NY) LLC	11.81%	2.25%	1,886,232	1,160,281	159.83%	3,781,895	Jun 30, 2024
VELAN CAPITAL INVESTMENT MANAGEMENT LP	8.08%	1.48%	1,290,323	1,290,323	100.00%	2,587,098	Jun 30, 2024
SIO CAPITAL MANAGEMENT, LLC	8.32%	0.72%	1,328,352	1,328,352	100.00%	2,663,346	Jun 30, 2024
AVIDITY PARTNERS MANAGEMENT LP	46.47%	0.63%	7,419,355	7,419,355	100.00%	14,875,807	Jun 30, 2024
DEEP TRACK CAPITAL, LP	46.47%	0.44%	7,419,355	7,419,355	100.00%	14,875,807	Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC	10.14%	0.37%	1,619,140	1,290,323	392.41%	3,246,376	Jun 30, 2024
ALTIUM CAPITAL MANAGEMENT LP	2.25%	0.29%	360,001	360,001	100.00%	721,802	Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC	4.04%	0.24%	645,161	439,227	213.29%	1,293,548	Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC	12.12%	0.23%	1,935,484	1,935,484	100.00%	3,880,645	Jun 30, 2024
CAXTON CORP	0.12%	0.19%	18,403	18,403	100.00%	36,899	Jun 30, 2024
DRIEHAUS CAPITAL MANAGEMENT LLC	14.14%	0.04%	2,258,065	2,258,065	100.00%	4,527,420	Jun 30, 2024
UBS OCONNOR LLC	1.84%	0.04%	293,758	-2,917	-0.98%	588,985	Jun 30, 2024
ALYESKA INVESTMENT GROUP, L.P.	12.12%	0.02%	1,935,484	1,935,484	100.00%	3,851,613	Jun 30, 2024
BLACKSTONE INC.	11.52%	0.02%	1,838,709	1,838,709	100.00%	3,686,612	Jun 30, 2024
CLEAR HARBOR ASSET MANAGEMENT, LLC	0.23%	0.01%	36,000	-	-	72,180	Jun 30, 2024
MILL CREEK CAPITAL ADVISORS, LLC	0.66%	0.01%	104,631	-	-	209,785	Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.26%	0.00%	41,469	-64,340	-60.81%	83,145	Jun 30, 2024

The largest Context Therapeutics shareholder by % of total assets is BLUE OWL CAPITAL HOLDINGS LP. The company owns 5.16M shares of Context Therapeutics (CNTX), representing 2.88% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
DEEP TRACK CAPITAL, LP	46.47%	0.44%	7,419,355	7,419,355	100.00%	14,875,807	Jun 30, 2024
AVIDITY PARTNERS MANAGEMENT LP	46.47%	0.63%	7,419,355	7,419,355	100.00%	14,875,807	Jun 30, 2024
NEXTECH INVEST LTD.	46.47%	2.50%	7,419,355	7,419,355	100.00%	14,875,807	Jun 30, 2024
GREAT POINT PARTNERS LLC	46.47%	2.85%	7,419,355	7,419,355	100.00%	14,875,807	Jun 30, 2024
BLUE OWL CAPITAL HOLDINGS LP	32.33%	2.88%	5,161,290	5,161,290	100.00%	10,348,386	Jun 30, 2024
VANGUARD GROUP INC	28.20%	0.00%	4,502,198	3,903,895	652.49%	9,026,907	Jun 30, 2024
DRIEHAUS CAPITAL MANAGEMENT LLC	14.14%	0.04%	2,258,065	2,258,065	100.00%	4,527,420	Jun 30, 2024
ALYESKA INVESTMENT GROUP, L.P.	12.12%	0.02%	1,935,484	1,935,484	100.00%	3,851,613	Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC	12.12%	0.23%	1,935,484	1,935,484	100.00%	3,880,645	Jun 30, 2024
BLACKSTONE INC.	11.52%	0.02%	1,838,709	1,838,709	100.00%	3,686,612	Jun 30, 2024
SIO CAPITAL MANAGEMENT, LLC	8.32%	0.72%	1,328,352	1,328,352	100.00%	2,663,346	Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC	10.14%	0.37%	1,619,140	1,290,323	392.41%	3,246,376	Jun 30, 2024
VELAN CAPITAL INVESTMENT MANAGEMENT LP	8.08%	1.48%	1,290,323	1,290,323	100.00%	2,587,098	Jun 30, 2024
ALLY BRIDGE GROUP (NY) LLC	11.81%	2.25%	1,886,232	1,160,281	159.83%	3,781,895	Jun 30, 2024
BLACKROCK INC.	5.33%	-	851,696	851,696	100.00%	1,707,650	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	3.87%	0.00%	618,174	517,102	511.62%	1,239,542	Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC	4.04%	0.24%	645,161	439,227	213.29%	1,293,548	Jun 30, 2024
ALTIUM CAPITAL MANAGEMENT LP	2.25%	0.29%	360,001	360,001	100.00%	721,802	Jun 30, 2024
NORTHERN TRUST CORP	1.09%	0.00%	174,497	137,278	368.84%	349,866,000	Jun 30, 2024
WALLEYE CAPITAL LLC	0.68%	0.00%	108,376	108,376	100.00%	217,294	Jun 30, 2024

As of Jun 30 2024, Context Therapeutics's largest institutional buyer is DEEP TRACK CAPITAL, LP. The company purchased 7.42M stocks of CNTX, valued at $14.88M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
OPALEYE MANAGEMENT INC.	-	-	-	-1,108,357	-100.00%	-	Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.26%	0.00%	41,469	-64,340	-60.81%	83,145	Jun 30, 2024
SHEETS SMITH WEALTH MANAGEMENT	-	-	-	-20,000	-100.00%	-	Jun 30, 2024
JEFFERIES FINANCIAL GROUP INC.	-	-	-	-11,453	-100.00%	-	Jun 30, 2024
XTX TOPCO LTD	-	-	-	-10,261	-100.00%	-	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-6,357	-100.00%	-	Jun 30, 2024
UBS OCONNOR LLC	1.84%	0.04%	293,758	-2,917	-0.98%	588,985	Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.	0.00%	-	500	-1,000	-66.67%	1,003	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-116	-100.00%	-	Jun 30, 2024
JPMORGAN CHASE & CO	-	-	-	-33	-100.00%	-	Jun 30, 2024
CLEAR HARBOR ASSET MANAGEMENT, LLC	0.23%	0.01%	36,000	-	-	72,180	Jun 30, 2024
MILL CREEK CAPITAL ADVISORS, LLC	0.66%	0.01%	104,631	-	-	209,785	Jun 30, 2024
HIGHTOWER ADVISORS, LLC	0.79%	0.00%	125,852	-	-	252,000	Jun 30, 2024
FEDERATION DES CAISSES DESJARDINS DU QUEBEC	0.00%	-	400	-	-	802	Jun 30, 2024
BANK OF AMERICA CORP /DE/	0.07%	-	10,776	10,776	100.00%	21,606	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	0.09%	0.00%	13,844	13,844	100.00%	27,757	Jun 30, 2024
VERITION FUND MANAGEMENT LLC	0.10%	0.00%	16,294	16,294	100.00%	32,669	Jun 30, 2024
CAXTON CORP	0.12%	0.19%	18,403	18,403	100.00%	36,899	Jun 30, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP	0.15%	0.00%	24,750	24,750	100.00%	50,000	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	0.41%	0.00%	65,200	25,300	63.41%	130,726	Jun 30, 2024

As of Jun 30 2024, Context Therapeutics's biggest institutional seller is OPALEYE MANAGEMENT INC.. The company sold -1.11M shares of CNTX, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
DEEP TRACK CAPITAL, LP	46.47%	0.44%	7,419,355	7,419,355	100.00%	14,875,807	Jun 30, 2024
AVIDITY PARTNERS MANAGEMENT LP	46.47%	0.63%	7,419,355	7,419,355	100.00%	14,875,807	Jun 30, 2024
NEXTECH INVEST LTD.	46.47%	2.50%	7,419,355	7,419,355	100.00%	14,875,807	Jun 30, 2024
GREAT POINT PARTNERS LLC	46.47%	2.85%	7,419,355	7,419,355	100.00%	14,875,807	Jun 30, 2024
BLUE OWL CAPITAL HOLDINGS LP	32.33%	2.88%	5,161,290	5,161,290	100.00%	10,348,386	Jun 30, 2024
DRIEHAUS CAPITAL MANAGEMENT LLC	14.14%	0.04%	2,258,065	2,258,065	100.00%	4,527,420	Jun 30, 2024
ALYESKA INVESTMENT GROUP, L.P.	12.12%	0.02%	1,935,484	1,935,484	100.00%	3,851,613	Jun 30, 2024
NANTAHALA CAPITAL MANAGEMENT, LLC	12.12%	0.23%	1,935,484	1,935,484	100.00%	3,880,645	Jun 30, 2024
BLACKSTONE INC.	11.52%	0.02%	1,838,709	1,838,709	100.00%	3,686,612	Jun 30, 2024
SIO CAPITAL MANAGEMENT, LLC	8.32%	0.72%	1,328,352	1,328,352	100.00%	2,663,346	Jun 30, 2024
VELAN CAPITAL INVESTMENT MANAGEMENT LP	8.08%	1.48%	1,290,323	1,290,323	100.00%	2,587,098	Jun 30, 2024
BLACKROCK INC.	5.33%	-	851,696	851,696	100.00%	1,707,650	Jun 30, 2024
ALTIUM CAPITAL MANAGEMENT LP	2.25%	0.29%	360,001	360,001	100.00%	721,802	Jun 30, 2024
WALLEYE CAPITAL LLC	0.68%	0.00%	108,376	108,376	100.00%	217,294	Jun 30, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP	0.15%	0.00%	24,750	24,750	100.00%	50,000	Jun 30, 2024
CAXTON CORP	0.12%	0.19%	18,403	18,403	100.00%	36,899	Jun 30, 2024
VERITION FUND MANAGEMENT LLC	0.10%	0.00%	16,294	16,294	100.00%	32,669	Jun 30, 2024
TWO SIGMA INVESTMENTS, LP	0.09%	0.00%	13,844	13,844	100.00%	27,757	Jun 30, 2024

Context Therapeutics's largest new institutional shareholder by number of shares is DEEP TRACK CAPITAL, LP, purchased 7.42M shares, valued at $14.88M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
OPALEYE MANAGEMENT INC.	-	-	-	-1,108,357	-100.00%	-	Jun 30, 2024
SHEETS SMITH WEALTH MANAGEMENT	-	-	-	-20,000	-100.00%	-	Jun 30, 2024
JEFFERIES FINANCIAL GROUP INC.	-	-	-	-11,453	-100.00%	-	Jun 30, 2024
XTX TOPCO LTD	-	-	-	-10,261	-100.00%	-	Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	-	-	-	-6,357	-100.00%	-	Jun 30, 2024
WELLS FARGO & COMPANY/MN	-	-	-	-116	-100.00%	-	Jun 30, 2024
JPMORGAN CHASE & CO	-	-	-	-33	-100.00%	-	Jun 30, 2024

Context Therapeutics's largest sold out institutional shareholder by shares sold is OPALEYE MANAGEMENT INC., sold -1.11M shares, valued at -, as of undefined.

Context Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
BRIDGEWAY FUNDS INC	0.04%	105,809	-	-	Mar 28, 2024
VANGUARD INDEX FUNDS	0.00%	598,303	-20,321	-3.28%	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	95,595	3,272	3.54%	Feb 29, 2024
NATIONWIDE MUTUAL FUNDS	0.00%	9,400	-	-	Jan 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	729	-	-	Jan 31, 2024
Blackstone Alternative Investment Funds	0.00%	100	100	-	Mar 31, 2023
iSHARES TRUST	0.00%	15,945	-	-	Mar 31, 2024
EQ ADVISORS TRUST	0.00%	1,016	-	-	Mar 31, 2024

Context Therapeutics's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 105.81K shares, compromising 0.04% of its total assets.

Context Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	3	-88.00%
31 Mar, 24	25	8.70%
31 Dec, 23	23	4.55%
30 Sep, 23	22	4.76%
30 Jun, 23	21	5.00%
31 Mar, 23	20	-9.09%
31 Dec, 22	22	4.76%
30 Sep, 22	21	23.53%
30 Jun, 22	17	41.67%
31 Mar, 22	12	-25.00%
31 Dec, 21	16	-

As of 30 Jun 24, 3 institutions are holding Context Therapeutics's shares, representing a decrease of -88.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	719,374	-81.72%
31 Mar, 24	3,935,132	10.59%
31 Dec, 23	3,558,239	38.01%
30 Sep, 23	2,578,256	15.16%
30 Jun, 23	2,238,766	74.01%
31 Mar, 23	1,286,606	-66.87%
31 Dec, 22	3,882,945	-6.00%
30 Sep, 22	4,130,839	13.42%
30 Jun, 22	3,641,962	25.39%
31 Mar, 22	2,904,420	-18.17%
31 Dec, 21	3,549,370	-

Context Therapeutics (CNTX) has 719.37K shares outstanding as of 30 Jun 24, down -81.72% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	4.51%	0.74%
31 Mar, 24	24.65%	4.96%
31 Dec, 23	22.29%	8.55%
30 Sep, 23	16.15%	8.21%
30 Jun, 23	14.02%	21.59%
31 Mar, 23	8.06%	1.36%
31 Dec, 22	24.32%	3.63%
30 Sep, 22	25.87%	4.97%
30 Jun, 22	22.81%	6.89%
31 Mar, 22	18.19%	1.51%
31 Dec, 21	34.76%	-

As of 30 Jun 24, Context Therapeutics is held by 4.51% institutional shareholders, representing a 0.74% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	2	-81.82%
31 Mar, 24	11	22.22%
31 Dec, 23	9	-10.00%
30 Sep, 23	10	-
30 Jun, 23	10	42.86%
31 Mar, 23	7	-41.67%
31 Dec, 22	12	-14.29%
30 Sep, 22	14	16.67%
30 Jun, 22	12	50.00%
31 Mar, 22	8	-50.00%
31 Dec, 21	16	-

2 institutional shareholders have increased their position in CNTX stock as of 30 Jun 24 compared to 11 in the previous quarter (a -81.82% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	-	-100.00%
31 Mar, 24	2	100.00%
31 Dec, 23	1	-
30 Sep, 23	1	-50.00%
30 Jun, 23	2	-66.67%
31 Mar, 23	6	-
31 Dec, 22	6	-
30 Sep, 22	-	-100.00%
30 Jun, 22	1	-50.00%
31 Mar, 22	2	-
31 Dec, 21	-	-

- institutional shareholders have reduced their position in CNTX stock as of 30 Jun 24 compared to 2 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	3	-88.00%	719,374	-81.72%	4.51%	0.74%	2	-81.82%	-	-100.00%
31 Mar, 24	25	8.70%	3,935,132	10.59%	24.65%	4.96%	11	22.22%	2	100.00%
31 Dec, 23	23	4.55%	3,558,239	38.01%	22.29%	8.55%	9	-10.00%	1	-
30 Sep, 23	22	4.76%	2,578,256	15.16%	16.15%	8.21%	10	-	1	-50.00%
30 Jun, 23	21	5.00%	2,238,766	74.01%	14.02%	21.59%	10	42.86%	2	-66.67%
31 Mar, 23	20	-9.09%	1,286,606	-66.87%	8.06%	1.36%	7	-41.67%	6	-
31 Dec, 22	22	4.76%	3,882,945	-6.00%	24.32%	3.63%	12	-14.29%	6	-
30 Sep, 22	21	23.53%	4,130,839	13.42%	25.87%	4.97%	14	16.67%	-	-100.00%
30 Jun, 22	17	41.67%	3,641,962	25.39%	22.81%	6.89%	12	50.00%	1	-50.00%
31 Mar, 22	12	-25.00%	2,904,420	-18.17%	18.19%	1.51%	8	-50.00%	2	-
31 Dec, 21	16	-	3,549,370	-	34.76%	-	16	-	-	-

Context Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Feb 21, 2023	Lehr Martin A.	director, officer	Chief Executive Officer	P-Purchase	Buy	5,823	$0.84	$4.90K	159,701
Feb 13, 2023	Lehr Martin A.	director, officer	Chief Executive Officer	P-Purchase	Buy	5,606	$0.87	$4.90K	153,878
Feb 06, 2023	Lehr Martin A.	director, officer	Chief Executive Officer	P-Purchase	Buy	5,040	$0.97	$4.90K	148,272
Jan 30, 2023	Lehr Martin A.	officer	Chief Executive Officer	P-Purchase	Buy	7,027	$0.70	$4.90K	143,232

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Feb 21, 2023	Lehr Martin A.	director, officer	Chief Executive Officer	P-Purchase	Buy	5,823	$0.84	$4.90K	159,701
Feb 13, 2023	Lehr Martin A.	director, officer	Chief Executive Officer	P-Purchase	Buy	5,606	$0.87	$4.90K	153,878
Feb 06, 2023	Lehr Martin A.	director, officer	Chief Executive Officer	P-Purchase	Buy	5,040	$0.97	$4.90K	148,272
Jan 30, 2023	Lehr Martin A.	officer	Chief Executive Officer	P-Purchase	Buy	7,027	$0.70	$4.90K	143,232

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 01, 2024	Dansky Ullmann Claudio	officer	Chief Medical Officer	A-Award	Buy	202,170	$2.23	$450.84K	202,170
Aug 01, 2024	Dansky Ullmann Claudio	officer	-		Buy	-	-	-	-
Jun 14, 2024	Stacey Jennifer Evans	director	-	A-Award	Buy	25,000	$1.97	$49.25K	25,000
Jun 14, 2024	Kantoff Philip W.	director	-	A-Award	Buy	25,000	$1.97	$49.25K	25,000
Jun 14, 2024	West Linda	director	-	A-Award	Buy	25,000	$1.97	$49.25K	25,000
Jun 14, 2024	BERMAN RICHARD J	director	-	A-Award	Buy	50,000	$1.97	$98.50K	50,000
Mar 22, 2024	Minai-Azary Jennifer Lynn	officer	Chief Financial Officer	A-Award	Buy	160,115	$1.07	$171.32K	160,115
Mar 22, 2024	Levit Alex C.	officer	Chief Legal Officer, Corp. Sec	A-Award	Buy	153,515	$1.07	$164.26K	153,515
Mar 22, 2024	Lehr Martin A.	director, officer	Chief Executive Officer	A-Award	Buy	291,402	$1.07	$311.80K	291,402
May 31, 2023	Kantoff Philip W.	director	-	A-Award	Buy	25,000	$0.87	$21.75K	25,000
May 31, 2023	West Linda	director	-	A-Award	Buy	25,000	$0.87	$21.75K	25,000
May 31, 2023	Stacey Jennifer Evans	director	-	A-Award	Buy	25,000	$0.87	$21.75K	25,000
May 31, 2023	BERMAN RICHARD J	director	-	A-Award	Buy	50,000	$0.87	$43.50K	50,000
Feb 21, 2023	Lehr Martin A.	director, officer	Chief Executive Officer	P-Purchase	Buy	5,823	$0.84	$4.90K	159,701
Feb 14, 2023	Levit Alex C.	officer	Chief Legal Officer, Corp. Sec	A-Award	Buy	151,505	$0.84	$127.37K	151,505
Feb 14, 2023	Lehr Martin A.	director, officer	Chief Executive Officer	A-Award	Buy	287,544	$0.84	$241.74K	287,544
Feb 14, 2023	Minai-Azary Jennifer Lynn	officer	Chief Financial Officer	A-Award	Buy	158,001	$0.84	$132.83K	158,001
Feb 13, 2023	Lehr Martin A.	director, officer	Chief Executive Officer	P-Purchase	Buy	5,606	$0.87	$4.90K	153,878
Feb 06, 2023	Lehr Martin A.	director, officer	Chief Executive Officer	P-Purchase	Buy	5,040	$0.97	$4.90K	148,272
Jan 30, 2023	Lehr Martin A.	officer	Chief Executive Officer	P-Purchase	Buy	7,027	$0.70	$4.90K	143,232

The last insider buy of CNTX was made by Lehr Martin A. on Feb 21 2023, buying 5,823 shares at $0.84 per share (worth $4.90K).

Context Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	1	-	-
Q2 2024	4	-	-
Q1 2024	3	-	-
Q2 2023	4	-	-
Q1 2023	9	-	-
Q4 2022	3	-	-
Q3 2022	4	-	-
Q2 2022	7	-	-
Q1 2022	5	-	-
Q4 2021	15	22	68.18%
Q4 2020	-	-	-

1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Context Therapeutics's insiders, as of Q3 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	-	-	-
Q2 2024	-	-	-
Q1 2024	-	-	-
Q2 2023	-	-	-
Q1 2023	6	-	-
Q4 2022	3	-	-
Q3 2022	3	-	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q4 2021	4	-	-
Q4 2020	-	-	-

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Context Therapeutics's stocks.

Context Therapeutics Peer Ownership

Ticker	Company
GRCL	Gracell Biotechnologies Inc.
XFOR	X4 Pharmaceuticals, Inc.
VECT	VectivBio Holding AG
NXTC	NextCure, Inc.
DAWN	Day One Biopharmaceuticals, Inc.
CTMX	CytomX Therapeutics, Inc.
SPRO	Spero Therapeutics, Inc.
TERN	Terns Pharmaceuticals, Inc.
BOLT	Bolt Biotherapeutics, Inc.
INZY	Inozyme Pharma, Inc.
ANNX	Annexon, Inc.
ASMB	Assembly Biosciences, Inc.
WVE	Wave Life Sciences Ltd.
ABOS	Acumen Pharmaceuticals, Inc.
INAB	IN8bio, Inc.
NLTX	Neurogene Inc.
CHRS	Coherus BioSciences, Inc.
ZURA	Zura Bio Limited
AMLX	Amylyx Pharmaceuticals, Inc.

CNTX Ownership FAQ

Who Owns Context Therapeutics?

Context Therapeutics is owned by institutional shareholders (4.51%), insiders (2.78%), and public (92.71%). The largest institutional shareholder of Context Therapeutics is GREAT POINT PARTNERS LLC (46.47% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.04% of total shares).

Who are the major institutional shareholders of Context Therapeutics?

Context Therapeutics's major institutional shareholders are GREAT POINT PARTNERS LLC, AVIDITY PARTNERS MANAGEMENT LP, DEEP TRACK CAPITAL, LP, NEXTECH INVEST LTD., and BLUE OWL CAPITAL HOLDINGS LP. The top five shareholders own together 218.20% of the company's share outstanding.

How many Context Therapeutics shareholders are there?

As of Jun 2024, there are 3 institutional shareholders of Context Therapeutics.

What percentage of Context Therapeutics is owned by GREAT POINT PARTNERS LLC?

GREAT POINT PARTNERS LLC owns 7.42M shares of Context Therapeutics, representing 46.47% of the company's total shares outstanding, valued at $14.88M (as of Jun 2024).

What percentage of Context Therapeutics is owned by AVIDITY PARTNERS MANAGEMENT LP?

As of Jun 2024, AVIDITY PARTNERS MANAGEMENT LP holds 7.42M shares of Context Therapeutics (CNTX), compromising 46.47% of the company, valued at $14.88M.

What percentage of Context Therapeutics is owned by DEEP TRACK CAPITAL, LP?

DEEP TRACK CAPITAL, LP is the third largest holder of Context Therapeutics. The company owns 7.42M of the company's shares outstanding (worth $14.88M).